Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib
- PMID: 16858202
- PMCID: PMC1602144
- DOI: 10.1097/01.sla.0000230021.24473.cf
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib
Comment on
-
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.Ann Surg. 2005 Jul;242(1):140-6. doi: 10.1097/01.sla.0000167847.53159.c1. Ann Surg. 2005. PMID: 15973112 Free PMC article.
Similar articles
-
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.Ann Surg. 2005 Jul;242(1):140-6. doi: 10.1097/01.sla.0000167847.53159.c1. Ann Surg. 2005. PMID: 15973112 Free PMC article.
-
Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma.J Pediatr Surg. 2011 Jan;46(1):108-14. doi: 10.1016/j.jpedsurg.2010.09.074. J Pediatr Surg. 2011. PMID: 21238650
-
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.Arterioscler Thromb Vasc Biol. 2006 May;26(5):1137-43. doi: 10.1161/01.ATV.0000216119.79008.ac. Epub 2006 Mar 2. Arterioscler Thromb Vasc Biol. 2006. PMID: 16514081
-
Chemopreventive effect of celecoxib in gastric cancer.Inflammopharmacology. 2007 Feb;15(1):1-4. doi: 10.1007/s10787-006-1541-5. Inflammopharmacology. 2007. PMID: 17323186 Review.
-
Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy.Br J Cancer. 2007 Dec 3;97(11):1465-8. doi: 10.1038/sj.bjc.6604049. Epub 2007 Oct 23. Br J Cancer. 2007. PMID: 17955049 Free PMC article. Review.
Cited by
-
Inhibition of cyclooxygenase-2 prevents intra-abdominal adhesions by decreasing activity of peritoneal fibroblasts.Drug Des Devel Ther. 2015 Jun 15;9:3083-98. doi: 10.2147/DDDT.S80221. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26109851 Free PMC article.
-
Techniques for navigating postsurgical adhesions: Insights into mechanisms and future directions.Bioeng Transl Med. 2023 Jun 26;8(6):e10565. doi: 10.1002/btm2.10565. eCollection 2023 Nov. Bioeng Transl Med. 2023. PMID: 38023705 Free PMC article. Review.
-
Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy.Redox Biol. 2021 Jan;38:101774. doi: 10.1016/j.redox.2020.101774. Epub 2020 Nov 1. Redox Biol. 2021. PMID: 33152664 Free PMC article.
-
Celecoxib effectively inhibits the formation of joint adhesions.Exp Ther Med. 2013 Dec;6(6):1507-1511. doi: 10.3892/etm.2013.1336. Epub 2013 Oct 9. Exp Ther Med. 2013. PMID: 24255682 Free PMC article.
References
-
- Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999;5:1418–1423. - PubMed
-
- Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res. 2002;17:963–976. - PubMed
-
- Cahill RA, Sheehan KM, Scanlon RW, et al. Effects of a selective cyclo-oygenase-2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg. 2004;91:1613–1618. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials